Ofatumumab Alternatives Compared
Ofatumumab | Imbruvica | Venetoclax |
|
---|
Ofatumumab | Imbruvica (ibrutinib) | Venetoclax |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis, Chronic Lymphocytic Leukemia. ofatumumab may also be used for purposes not listed in this medication guide. |
Prescription only
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Prescription only
Prescribed for Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia. venetoclax may also be used for purposes not listed in this medication guide. |
||||||||
More about Ofatumumab | More about Imbruvica (ibrutinib) | More about Venetoclax | ||||||||
Ratings & Reviews | ||||||||||
Ofatumumab has an average rating of 6.7 out of 10 from a total of 61 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 22% reported a negative effect. |
Imbruvica has an average rating of 6.3 out of 10 from a total of 60 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 34% reported a negative effect. |
Venetoclax has an average rating of 8.6 out of 10 from a total of 10 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: ofatumumab side effects in more detail. |
See also: Imbruvica side effects in more detail. |
See also: venetoclax side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Imbruvica prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Arzerra, Kesimpta |
N/A |
Venclexta | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
1476 hours |
6 hours |
26 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 166 drugs are known to interact with ofatumumab:
|
A total of 457 drugs are known to interact with Imbruvica:
|
A total of 422 drugs are known to interact with venetoclax:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
October 26, 2009 |
November 13, 2013 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.